IRONWOOD PHARMACEUTICALS INC: STATE STREET CORP discloses a stake of more than 5% (Schedule 13G)
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
State Street Corp has disclosed a stake exceeding 5% in Ironwood Pharmaceuticals Inc. via a Schedule 13G filing with the SEC (accession 0000093751-26-000678). The passive institutional position signals continued major-holder interest in the biopharmaceutical company. The exact share count and percentage were not specified in the filing headline. Investors will watch for further 13G/13D amendments and Ironwood's next quarterly update for any shift in institutional ownership.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Ironwood Pharmaceuticals Inc, State Street Corp